Topiramate
Product Images NDC 50436-0139

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 50436-0139). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Product Formula For Topiramate (16e9304c A029 4d23 Ae3f E197def9a302 01)

Structured Product Formula For Topiramate (16e9304c A029 4d23 Ae3f E197def9a302 01)
Chemical structure diagram of topiramate, depicting its molecular bonds and functional groups as shown in the image.*
FDA Label Image

Structured Product Formula For Topiramate (16e9304c A029 4d23 Ae3f E197def9a302 02)

Structured Product Formula For Topiramate (16e9304c A029 4d23 Ae3f E197def9a302 02)
A Kaplan-Meier survival curve graph showing cumulative seizure-free rates over time (days) for two doses of topiramate: 50 mg/day and 400 mg/day. The x-axis represents time in days, and the y-axis shows cumulative probability of time to first seizure, comparing 234 subjects at 50 mg/day and 236 subjects at 400 mg/day.*
FDA Label Image

Topiramate Tablets Usp (16e9304c A029 4d23 Ae3f E197def9a302 03)

Topiramate Tablets Usp (16e9304c A029 4d23 Ae3f E197def9a302 03)
A bar chart showing change from baseline to double-blind phase in average monthly migraine period rate with standard error. Data compares placebo and three dosages of topiramate (50 mg/day, 100 mg/day, 200 mg/day) across two studies, with sample sizes noted for each group on the x-axis and significance levels indicated for some bars.*
FDA Label Image

Label Image (Lbl504360139)

Label Image (Lbl504360139)
Label for Topiramate 50 mg tablets, package of 30, distributed by Unit Dose Services. This unit dose label includes dosage strength, quantity, manufacturer information (Cadila Healthcare Ltd., Ahmedabad, India), and handling warnings. Multiple barcode and NDC details are also present for tracking and identification.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.